CareDx, Inc.·4

Jan 23, 5:58 PM ET

Hanna John Walter JR 4

Research Summary

AI-generated summary

Updated

CareDx (CDNA) CEO John W. Hanna Jr. Sells 19,480 Shares

What Happened

  • John W. Hanna Jr., President, CEO and a director of CareDx (CDNA), sold a total of 19,480 shares in open-market transactions. He disposed of 200 shares on 2026-01-21 at $21.00 ($4,200) and 19,280 shares on 2026-01-22 at a weighted average price of $21.16 (≈ $408,023). Combined proceeds were about $412,223. These were sales (S), which are typically routine dispositions rather than purchases indicating new insider conviction.

Key Details

  • Transaction dates and prices:
    • 2026-01-21: 200 shares sold at $21.00 (total $4,200).
    • 2026-01-22: 19,280 shares sold at a weighted average price of $21.16 (≈ $408,023); reported price range for these trades was $21.00–$21.43 per share.
  • Total shares sold: 19,480; total proceeds ≈ $412,223.
  • Shares owned after transaction: Not specified in the summary provided here — see the Form 4 for updated holdings.
  • Notable footnotes:
    • The 2026 sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2024 (prearranged plan).
    • The weighted average price reflects multiple trades; the filer can provide a breakdown of shares sold at each price on request.
  • Filing timeliness: Form 4 was filed on 2026-01-23 for transactions on 2026-01-21 and 2026-01-22; no late filing is indicated.

Context

  • These sales were executed under a pre-established 10b5-1 plan, which generally allows insiders to sell according to a predetermined schedule and reduces the likelihood that the trades reflect immediate insider views on company prospects. Sales do not necessarily signal negative information about the company; purchases are typically more informative about insider sentiment.